PURPOSE 2

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection

Oral Lenacapavir (LEN)OngoingActive not recruitingPhase 3Open NCT04925752 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…